Back to VG Vanguard Global Advisers, LLCCNCNSY
CNCNSY1 quarters
Position history for VGVanguard Global Advisers, LLC's holdings in PLUS THERAPEUTICS INC
Yes. Vanguard Global Advisers holds 2,282 shares of CNSY (Plus Therapeutics), worth $9,972, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$9,972
Current Shares
2,282
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of CNSY: VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, VANGUARD FIDUCIARY TRUST CO, STATE STREET CORP